J&J Seeks Fed. Circ. Rehearing On Stent Patents

Law360, New York (July 27, 2011, 1:45 PM EDT) -- Johnson & Johnson asked the Federal Circuit last week to rehear its appeal of a decision in favor of Boston Scientific Corp. that deemed four J&J patents for drug-eluting stents invalid for lack of adequate written description.

In a petition for rehearing or rehearing en banc lodged on July 21, J&J contends that a Federal Circuit panel erred when it concluded in June that a Delaware federal court had properly granted summary judgment to BSC because it had correctly ruled that the four patents did not...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.